Severe bone defects in the jaws.
Conditions
Interventions
Intervention 1: Control group: Lidocaine local anesthetic 2% - Persocaine-E (lidocaine) 2% manufactured by Daroopakhsh company - each cartridge contains 1.8 ml anesthetic solution - 12.5 micrograms ep
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: People between 18 and 65 years old Systemically healthy people Having the ability to fill out questionnaires People with bone defects in the edentulous area and candidate for bone graft People who need implants in the upper jaw or the opposite side of the bone removal area in the lower jaw (contralateral)
Exclusion criteria
Exclusion criteria: Presence of an abscess or any pathological lesion at the injection site History of diabetes, cardiovascular diseases, hypertension and kidney diseases History of allergy to Lidocaine or Articaine local anesthetics Consumption of alcohol or any pain reliever Mentally unable to give informed consent pregnancy and breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of people who have pain during surgery. Timepoint: The presence of pain during surgery and throughout its duration. Method of measurement: Asking the patient about the presence or absence of pain. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir Hasanpour
Qazvin University of Medical Sciences
Outcome results
None listed